Recent studies have shown that short-term IGF-1 treatment (1 μg/g/day) using an osmotic minipump for 3 days after acute myocardial infarction improves cardiac function by modulating the acute inflammatory phase but does not alleviate fibrosis [27]. This evidence concerns the gene IGF1 and myocardial infarction.